| Filed On | Filing |
|---|---|
| 09 Oct 2020 |
Form 3: O'Reilly Kevin, SVP, President of Oncology Sys
Holds 0 shares of No securities beneficially owned |
| 25 Jun 2020 | Form 3: Varian Medical Systems Inc, 10% owner · Fusion Pharmaceuticals Inc. |
| 08 Jun 2020 |
Form 3: Hutchinson Michael Damon, SVP,Chief Legal Officer, Secy
Holds 0 shares of No securities beneficially owned |
| 10 Dec 2019 |
Form 3: Bruff Jesse Michael, SVP Finance, CFO
Holds 550 shares of Common Stock |
| 03 Dec 2019 |
Form 3: Le Beau Michelle, Director
Holds 0 shares of No securities beneficially owned |
| 28 Aug 2019 |
Form 3: Febbo Phillip G., Director
Holds 0 shares of No securities beneficially owned |
| 13 Dec 2018 |
Form 3: Ashkenazi Anat, Director
Holds 0 shares of No securities beneficially owned |
| 10 Oct 2018 | Form 3: Toth Christopher A., SVP and Pres. Oncology Systems |
| 01 Oct 2018 |
Form 3: Balser Jeffrey R., Director
Holds 0 shares of No securities beneficially owned |
| 11 May 2017 |
Form 3: Bischoping Gary E Jr, SVP, Finance & CFO
Holds 0 shares of No securities beneficially owned |
| 01 Mar 2017 |
Form 3: Baselga Jose, Director
Holds 0 shares of No securities beneficially owned |
| 01 Mar 2017 |
Form 3: Butel Jean Luc, Director
Holds 0 shares of No securities beneficially owned |
| 06 Feb 2017 |
Form 3: Momsen Magnus, SVP, CAO, Corporate Controller
Holds 5,116 shares of Common Stock |
| 19 Jan 2017 |
Form 3: Varian Medical Systems Inc, 10% owner · Varex Imaging Corporation
Holds 100 shares of Common Stock |
| 25 Aug 2016 |
Form 3: Bruner Judy, Director
Holds 0 shares of No securities beneficially owned |
| 07 Feb 2014 |
Form 3: Sanyal Sunny, SVP and President, ICB
Holds 0 shares of No securities beneficially owned |
| 17 Dec 2013 |
Form 3: Dugan Regina E, Director
Holds 0 shares of No securities beneficially owned |
| 17 Aug 2012 |
Form 3: Verhoef Clarence R, SVP, Finance, Corp Controller
Holds 4,175 shares of Common Stock |
| 17 Aug 2012 |
Form 3: Reinhardt Erich R, Director
Holds 0 shares of No securities beneficially owned |
| 04 Oct 2011 |
Form 3: Kennedy Kolleen T, SVP and Pres. Oncology Sys.
Holds 13,256 shares of Common Stock |
Loading...
